Dr.Muthulingam C
About Dr.Muthulingam C
Dr. Muthulingam C serves as the Senior Vice President at Mankind Pharma Ltd, where he oversees the formulation development center focused on generic drug products for the US market. He has a robust academic background in pharmaceutical sciences, holding a PhD, and extensive experience in leading complex drug formulation projects across various pharmaceutical companies.
Work at MANKIND PHARMA LTD
Dr. Muthulingam C currently serves as the Senior Vice President at MANKIND PHARMA LTD. He oversees the formulation development center, focusing on the delivery of generic drug products for the US market. His role involves managing complex projects and ensuring compliance with industry standards.
Education and Expertise
Dr. Muthulingam C holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Jaipur National University, which he completed from 2011 to 2014. He also earned a B.Pharmacy and an M.Pharma in Pharmaceutics from Tamil Nadu Doctor M.G.R. Medical University. Additionally, he obtained a Post Graduate Diploma in International Business from Symbiosis Centre for Distance Learning between 2010 and 2012.
Background
Dr. Muthulingam C has extensive experience in the pharmaceutical industry, having worked in various roles across multiple organizations. His career includes positions at Ranbaxy, Aurobindo Pharma, Micro Labs Ltd., Alembic, and Dr. Reddy's Laboratories. He has a strong focus on formulation development for international markets.
Professional Experience
Prior to his current role at MANKIND PHARMA LTD, Dr. Muthulingam held several significant positions. He worked as Associate Vice President at Aurobindo Pharma from 2015 to 2019, and as Principal Scientist-II from 2013 to 2015. His earlier roles include Senior Research Scientist at Ranbaxy and Group Leader at Piramal Pharmaceutical Development Services.
Achievements in Pharmaceutical Development
Dr. Muthulingam C has a proven track record in leading the development of complex generic drug formulations. His expertise in pharmaceutical sciences has contributed to advancements in drug formulation and delivery systems, particularly for the US market.